Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 12, 2022

SELL
$45.75 - $56.69 $168,131 - $208,335
-3,675 Closed
0 $0
Q4 2021

Feb 01, 2022

BUY
$41.32 - $61.25 $151,851 - $225,093
3,675 New
3,675 $218,000
Q3 2021

Oct 08, 2021

SELL
$39.25 - $50.42 $242,368 - $311,343
-6,175 Closed
0 $0
Q2 2021

Jul 19, 2021

SELL
$35.91 - $40.68 $304,337 - $344,763
-8,475 Reduced 57.85%
6,175 $241,000
Q1 2021

Apr 20, 2021

SELL
$33.49 - $37.77 $40,188 - $45,324
-1,200 Reduced 7.57%
14,650 $533,000
Q4 2020

Jan 26, 2021

SELL
$33.47 - $42.56 $177,391 - $225,568
-5,300 Reduced 25.06%
15,850 $583,000
Q3 2020

Nov 10, 2020

SELL
$31.75 - $37.25 $25,400 - $29,800
-800 Reduced 3.64%
21,150 $771,000
Q1 2020

May 06, 2020

SELL
$27.03 - $38.62 $1.65 Million - $2.36 Million
-61,050 Reduced 73.55%
21,950 $716,000
Q4 2019

Jan 15, 2020

BUY
$32.92 - $37.36 $2.26 Million - $2.56 Million
68,500 Added 472.41%
83,000 $3.09 Million
Q3 2019

Oct 29, 2019

SELL
$32.49 - $42.13 $113,715 - $147,455
-3,500 Reduced 19.44%
14,500 $494,000
Q2 2019

Jul 22, 2019

SELL
$36.98 - $41.52 $96,147 - $107,952
-2,600 Reduced 12.62%
18,000 $0
Q1 2019

May 14, 2019

SELL
$37.5 - $41.2 $30,000 - $32,960
-800 Reduced 3.74%
20,600 $874,000
Q4 2018

Jan 18, 2019

SELL
$38.47 - $43.86 $7,694 - $8,772
-200 Reduced 0.93%
21,400 $886,000
Q3 2018

Oct 17, 2018

SELL
$34.47 - $41.81 $3,447 - $4,181
-100 Reduced 0.46%
21,600 $951,000
Q2 2018

Jul 24, 2018

SELL
$32.98 - $35.16 $1,648 - $1,757
-50 Reduced 0.23%
21,700 $787,000
Q1 2018

Apr 19, 2018

SELL
$31.91 - $37.02 $3.26 Million - $3.78 Million
-102,180 Reduced 82.45%
21,750 $771,000
Q4 2017

Feb 05, 2018

SELL
$33.26 - $35.29 $731,720 - $776,380
-22,000 Reduced 15.08%
123,930 $0
Q3 2017

Oct 20, 2017

BUY
$31.0 - $34.15 $4.52 Million - $4.98 Million
145,930
145,930 $5.21 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Eidelman Virant Capital Portfolio

Follow Eidelman Virant Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eidelman Virant Capital, based on Form 13F filings with the SEC.

News

Stay updated on Eidelman Virant Capital with notifications on news.